Intratumoral Metabolic Heterogeneity for Prediction of Disease Progression After Concurrent Chemoradiotherapy in Patients with Inoperable Stage III Non-Small-Cell Lung Cancer

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions